JPS61267541A - 抗脂血剤 - Google Patents

抗脂血剤

Info

Publication number
JPS61267541A
JPS61267541A JP61002624A JP262486A JPS61267541A JP S61267541 A JPS61267541 A JP S61267541A JP 61002624 A JP61002624 A JP 61002624A JP 262486 A JP262486 A JP 262486A JP S61267541 A JPS61267541 A JP S61267541A
Authority
JP
Japan
Prior art keywords
formula
formulas
lower alkoxy
ring
tables
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61002624A
Other languages
English (en)
Japanese (ja)
Inventor
Tameo Iwasaki
岩崎　為雄
Koki Takashima
高島　絋毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of JPS61267541A publication Critical patent/JPS61267541A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/337—Polycyclic acids with carboxyl groups bound to condensed ring systems
    • C07C63/34—Polycyclic acids with carboxyl groups bound to condensed ring systems containing two condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
JP61002624A 1985-01-10 1986-01-08 抗脂血剤 Pending JPS61267541A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60-3090 1985-01-10
JP309085 1985-01-10

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP63310353A Division JPH0272136A (ja) 1985-01-10 1988-12-08 ナフタレン誘導体、その製法及びその合成中間体
JP63310354A Division JPH0272170A (ja) 1985-01-10 1988-12-08 ナフトエ酸ラクトン誘導体
JP31035588A Division JPH06724B2 (ja) 1988-12-08 1988-12-08 ナフタレン誘導体

Publications (1)

Publication Number Publication Date
JPS61267541A true JPS61267541A (ja) 1986-11-27

Family

ID=11547645

Family Applications (3)

Application Number Title Priority Date Filing Date
JP61002624A Pending JPS61267541A (ja) 1985-01-10 1986-01-08 抗脂血剤
JP63310353A Pending JPH0272136A (ja) 1985-01-10 1988-12-08 ナフタレン誘導体、その製法及びその合成中間体
JP63310354A Granted JPH0272170A (ja) 1985-01-10 1988-12-08 ナフトエ酸ラクトン誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP63310353A Pending JPH0272136A (ja) 1985-01-10 1988-12-08 ナフタレン誘導体、その製法及びその合成中間体
JP63310354A Granted JPH0272170A (ja) 1985-01-10 1988-12-08 ナフトエ酸ラクトン誘導体

Country Status (18)

Country Link
US (2) US4771072A (enExample)
EP (1) EP0188248B1 (enExample)
JP (3) JPS61267541A (enExample)
KR (1) KR890001884B1 (enExample)
CN (1) CN1006464B (enExample)
AT (1) ATE54441T1 (enExample)
AU (1) AU584153B2 (enExample)
BG (2) BG45385A3 (enExample)
DD (1) DD270529A5 (enExample)
DE (1) DE3672501D1 (enExample)
ES (2) ES8705837A1 (enExample)
FI (1) FI87557C (enExample)
HU (1) HU196737B (enExample)
IL (1) IL91117A0 (enExample)
MY (1) MY101268A (enExample)
NO (1) NO170760C (enExample)
PH (1) PH22105A (enExample)
PT (1) PT81814B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629381B2 (en) 2001-06-19 2009-12-08 Axelar Ab Use of specific cyklolignans

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
US5011948A (en) * 1985-04-12 1991-04-30 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
JPS6310746A (ja) * 1986-07-01 1988-01-18 Tanabe Seiyaku Co Ltd ナフタレン誘導体
AT388372B (de) * 1987-10-08 1989-06-12 Tanabe Seiyaku Co Neue naphthalinderivate und sie enthaltende pharmazeutika
JPH01135766A (ja) * 1987-11-20 1989-05-29 Tanabe Seiyaku Co Ltd ビフェニル誘導体
PH26342A (en) * 1988-11-29 1992-04-29 Univ Texas Microbial cellulose modified during synthesis
MY105057A (en) * 1989-01-27 1994-07-30 Tanabe Seiyaku Co A process for preparing naphthalene derivatives
ZA9076B (en) * 1989-02-03 1990-10-31 Tanabe Seiyaku Co Limited A process for preparing a naphthalene derivative and a synthetic intermediate thereof
US5227399A (en) * 1991-02-28 1993-07-13 Merck Frosst Canada, Inc. Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis
US5281720A (en) * 1991-02-28 1994-01-25 Merck Frosst Canada, Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
EP0501578A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
EP0501579A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Naphthalene lactones as inhibitors of leukotriene biosynthesis
ES2129733T3 (es) * 1991-10-17 1999-06-16 Shionogi & Co Procedimiento de preparacion de analogos de la lignina y productos de partida para estos.
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
US5350744A (en) * 1992-08-27 1994-09-27 Merck Frosst Canada, Inc. Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5426109A (en) * 1992-08-27 1995-06-20 Merck Frosst Canada, Inc. Phenylnaphthalene hydroxy acids
US5252599A (en) * 1992-08-27 1993-10-12 Merck Frosst Canada, Inc. Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
BR9913333A (pt) * 1998-08-25 2001-05-15 Univ Yale Inibição e tratamento do vìrus da hepatite b e flavivìrus com helioxatina e seus análogos
US6646005B1 (en) 1999-06-01 2003-11-11 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
AU3507700A (en) 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using diphenylether derivatives
CA2459017A1 (en) * 2001-08-28 2003-03-13 Sankyo Company, Limited Medicinal compositions containing angiotensin ii receptor antagonist
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CN107375932B (zh) 2011-10-28 2021-12-21 夏尔人类遗传性治疗公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
JP6217939B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 高胆汁血症および胆汁うっ滞性肝疾患の処置のための胆汁酸再利用阻害剤
JP2016514678A (ja) 2013-03-15 2016-05-23 ルメナ ファーマシューティカルズ エルエルシー バレット食道と胃食道逆流性疾患を処置するための胆汁酸再利用阻害剤
MX2015013193A (es) 2013-03-15 2016-04-15 Lumena Pharmaceuticals Inc Inhibidores del reciclaje de acidos biliares para el tratamiento de colangitis esclerosante primaria y enfermedad inflamatoria intestinal.
US20170119806A1 (en) * 2014-03-31 2017-05-04 Ohio State Innovation Foundation Arylnaphthalene lactone derivatives and methods of making and using thereof
WO2017147624A1 (en) 2016-02-26 2017-08-31 Ohio State Innovation Foundation Antitumor arylnaphthalene ligand glycosides
WO2020167958A1 (en) 2019-02-12 2020-08-20 Mirum Pharmaceuticals, Inc. Methods for treating cholestasis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629381B2 (en) 2001-06-19 2009-12-08 Axelar Ab Use of specific cyklolignans
US7662851B2 (en) 2001-06-19 2010-02-16 Axelar Ab Use of specific cyklolignans
US7709526B2 (en) 2001-06-19 2010-05-04 Biovitrum Ab Use of cyclolignans and new cyclolignans
US8389747B2 (en) 2001-06-19 2013-03-05 Axelar Ab Use of specific cyklolignans

Also Published As

Publication number Publication date
JPH0549668B2 (enExample) 1993-07-26
PH22105A (en) 1988-06-01
PT81814A (en) 1986-02-01
PT81814B (pt) 1988-07-29
ES550578A0 (es) 1987-05-16
BG45383A3 (bg) 1989-05-15
JPH0272136A (ja) 1990-03-12
DD270529A5 (de) 1989-08-02
FI87557C (fi) 1993-01-25
EP0188248A3 (en) 1986-12-17
HUT42428A (en) 1987-07-28
ATE54441T1 (de) 1990-07-15
CN1006464B (zh) 1990-01-17
US4771072A (en) 1988-09-13
FI87557B (fi) 1992-10-15
KR860005778A (ko) 1986-08-13
ES8705837A1 (es) 1987-05-16
EP0188248A2 (en) 1986-07-23
JPH0272170A (ja) 1990-03-12
KR890001884B1 (ko) 1989-05-29
AU5175185A (en) 1986-07-17
HU196737B (en) 1989-01-30
ES8801239A1 (es) 1987-12-16
ES557052A0 (es) 1987-12-16
FI860089L (fi) 1986-07-11
NO170760B (no) 1992-08-24
NO170760C (no) 1992-12-02
DE3672501D1 (de) 1990-08-16
MY101268A (en) 1991-08-17
AU584153B2 (en) 1989-05-18
US5070103A (en) 1991-12-03
BG45385A3 (bg) 1989-05-15
NO855355L (no) 1986-07-11
IL91117A0 (en) 1990-03-19
CN86100090A (zh) 1986-08-20
EP0188248B1 (en) 1990-07-11
FI860089A0 (fi) 1986-01-09

Similar Documents

Publication Publication Date Title
JPS61267541A (ja) 抗脂血剤
US4840951A (en) Novel naphthalene derivative
EP0017195A1 (en) Derivatives of 2,5-disubstituted-cyclohexane-1,3-diones, process for preparation thereof and pharmaceutical composition containing them
JPH11505236A (ja) フェニルジヒドロベンゾフラン
DE69008205T2 (de) Abkömmlinge von Benzocycloalkenyldihydroxyalkansäuren, Verfahren zu deren Herstellung und diese enthaltende Pharmazeutika.
AT388372B (de) Neue naphthalinderivate und sie enthaltende pharmazeutika
US4413006A (en) N-Aryl-N-phenoxy-alkyl-piperazine compounds useful in decreasing intracranial pressure
JPH0660138B2 (ja) ジ−及びテトラ−ヒドロナフタレン類，その製法及びそれを含む医薬組成物
US4567180A (en) Carboximide derivative and medicines containing same
US4515980A (en) Substituted aminobenzoates, their preparation and use
EP0034116A2 (en) N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
EP0351255A2 (fr) Dérivés de [(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
JPH01250316A (ja) 抗脂血剤
JPS63295566A (ja) キノキサリノン誘導体
EP0149419B1 (en) Acylindole derivatives and pharmaceutical compositions containing them
FR2492378A1 (fr) Derives de type 6h-dibenzo(b,d) pyranne 6-substitues utiles notamment comme medicaments antiulcereux, immunomodulateurs et antiviraux et procedes de leur preparation
KR920000910B1 (ko) 나프탈렌 유도체
US4622336A (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives, processes for their production and pharmaceutical compositions comprising them
US4631283A (en) Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids
EP0663395B1 (de) 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als herzfrequenzsenkendes Mittel
US4129658A (en) 4-Styryl-hexahydro-4-indolinols
US4897418A (en) Novel naphthalene derivative
JPH01313460A (ja) Ｎ‐置換されたｎ‐アミノ‐ピロール
JPH01135766A (ja) ビフェニル誘導体
US4622329A (en) 1-cyclohexyl-3,4-dihydroisoquinoline derivatives and pharmaceutical compositions containing them